Our Members

As a member-focused Association, our members are at the heart of everything we do at the PRI.

In principle any organization (public or private) is eligible to join the Association and become part of Europe’s growing microbiome-based medicinal product ecosystem.

Find out more about the different ways you and your organization can get involved with the PRI’s activities.

  • Microbiome Regulatory Science Support Work
  • Pre-competitive Task Groups
  • Year-round networking and project-related communication support

Nearly 90 PRI Members from 24 countries represent nearly every point along the microbiome science and development continuum, from fundamental research groups all the way to commercial manufacturing partners and pharmaceutical companies.

Accelsiors AG

Accelsiors AG

Hélène Cvejic

Director Translational Science and Clinical Research Hubs

Accelsiors is a leading international CRO. We support and accelerate each step of the clinical drug development, from the preclinical consultation stage throughout the whole clinical development.

 

ADM

ADM

Carol Lemos

RSA Strategy and Development Lead - Food & Pharma

As one of the world’s largest nutrition companies, ADM is a leader in both human and animal nutrition.

 

Aptar CSP Technologies

Aptar CSP Technologies

Francois Bidet

Vice-President of Business Development

Aptar CSP Technologies provides highly engineered packaging solutions to meet Probiotics stability needs. Through our Activ-Polymer, moisture and/or oxygen levels are reduced allowing a longer shelflife.

 

Arranta Bio

Arranta Bio

Melanie Cerullo

Chief Quality & Regulatory Officer

Arranta Bio provides novel solutions to clients for advanced therapy process development and manufacturing. Our expertise and ability to provide end-to-end solutions helps guide advanced therapeutic products through the clinical journey to the commercial. We focus on partnership and tailor our solutions to each company’s unique needs.

 

Astel Medica

Astel Medica

Nail Nasir

Scientific Manager

Astel Medica is a fast growing belgian pharmaceutical company. Founded in 1988 with the collaboration of the University of Liège, Astel Medica is the Belgian leader in the conception and manufacturing of innovative evidence based symbiotics. Working in collaboration with 7 universities, Astel Medica invests in Research and Development as to provide the best Probiotics on the market.

 

Atlantia Clinical Trials

Atlantia Clinical Trials

We are a world-class provider of human clinical studies. We perform acute, observational, PK/PD, pivotal, efficacy, and intervention studies to ICH-GCP standards for microbiome products.

      

University of Antwerp

University of Antwerp

Sarah Lebeer

Research Professor

Our 'Laboratory of Applied Microbiology and Biotechnology' is specialized in academic fundamental and applied research on the human microbiome (mainly vagina, upper respiratory tract & skin) and how microbiome-based therapeutics can be developed based on microbiome insights. We have a particular interest for lactobacilli in different parts of the human body and expertise in how to formulate these lactobacilli in suitable application forms for different bidy sites and how to run clinical trials to show clinical and microbiome efficacy.

 

Bacthera

Bacthera

Oliver Ravn

Marketing and Market Intelligence Associate

Leading CDMO in the LBP industry

 

BaseClear BV

BaseClear BV

Radhika Bongoni

Commercial Director

Founded in 1993, we are a pioneer on the market and have been on the forefront of the microbial genomics revolution. We are the preferred partner for many leading brands in various industries such as human health, personal care and animal nutrition in the Netherlands, in Europe and beyond. We support our clients in improving their processes and products, gaining approval and confirming claims.

 

Bio-Me AS

Bio-Me AS

Warren Flood

CEO

Powering Microbiome Research and Diagnostics Development: qPCR-based platform is transforming microbiome analysis by enabling high-volume precision microbiome profiling.

 

BIOASTER

BIOASTER

Established in 2012, BIOASTER is a private, non-profit Foundation that works to develop innovative technologies to support the latest challenges in microbiology research.

 

Biofortis

Biofortis

Françoise Le Vacon

CSO

Biofortis is a unique full services CRO providing Nutrition Clinical Trials, Microbiome Investigation and Data Science for Human and Animal Health.

 

Biomeostasis

Biomeostasis

Bruno Bariohay

CEO

BIOMEOSTASIS provides preclinical in vivo pharmacology services in the field of metabolic, GI and aged-related disorders.

 

Biomica

Biomica

Elran Haber

CEO

Biomica is an emerging biopharmaceutical company developing innovative microbiome-based therapeutics for the treatment of immune-mediated and infectious diseases, with specific focus on Immuno-Oncology and GI related disorders.

 

Biose Industrie

Biose Industrie

Richard Ellis

Business Development

Founded in 1951 by pharmacists and microbiologists, biose® industrie has 70-years experience in drugs based on live bacteria, giving us a deep understanding of the entire process from discovery to commercialization. Focused on Health through microbiota and microbiome science, we use our skills for the discovery, product development, clinical studies and manufacturing of Live Biotherapeutic Products (LBP). Our company is drug-GMP certified for the manufacturing of bacteria-based Drug Substance and Drug Product for clinical and commercial applications.

 

Boehringer Ingelheim

Boehringer Ingelheim

Anne Cadoux

Head of Regulatory Affairs Animal Health Care Products

Boehringer Ingelheim Animal Health France is born from Merial in 2018 further to the acquisition of Merial by Boehringer Ingelheim, a large pharmaceutical company with a small Animal Health department. Now 2nd biggest company in the world for Animal Health products. Innovation is one of its characteristics.

 

BoobyBiome

BoobyBiome

Lydia Mapstone

Co-Founder & CEO

BoobyBiome, a female-led UK-micro SME, is developing a rationally-designed live biotherapeutic product (LBP) tailored for babies with compromised microbiomes. Informed by rigorous scientific testing and precise characterisation of breast milk, the LBP will replenish the infant gut to a healthier state.

 

Caelus Health

Caelus Health

Luc Sterkman

CEO

Caelus Health is an Amsterdam-based biotech company with in-depth knowledge of the microbiome, dedicated to the development and commercialization of microbiota-based products to prevent and treat cardiometabolic disorders, including Diabetes, and other unmet medical needs. The company has built a strong patented-protected proprietary position for the treatment of Diabetes Mellitus Type 1 and Type 2, cancer cachexia and auto-immune diseases.

 

Clinical Microbiomics

Clinical Microbiomics

Anders Grøn

Chief Executive Officer

Clinical Microbiomics is the world's leading provider of metagenomics analyses advancing microbiome analyses across industry and academia.

 

CosmosID

CosmosID

Mo Langhi

Director, Business Development

CosmosID® is a global leader in supporting the pharmaceutical sector with CLIA-certified, ICH-GCP compliant microbiome and microbial isolate solutions for applications such as pre-clinical, clinical, CMC and regulatory support. In addition to Next Generation Sequencing workflows, CosmosID also offers validated, industry-leading bioinformatics, yielding multi-kingdom, strain-level resolution with leading sensitivity and precision.

 

Cryptobiotix

Cryptobiotix

Aurélien Baudot

CEO

Early & late preclinical research for a fast & informative gut microbiome product development.

 

Destiny Pharma

Destiny Pharma

Debra Barker

CMO

Destiny Pharma is a clinical phase biotechnology company dedicated to the development of novel anti-infectives with a focus on infection prevention.

 

Don Whitley Scientific Limited

Don Whitley Scientific Limited

Andrew Pridmore

Head of Science

GLP compliant contract microbiological laboratory services, specializing in antibiotic susceptibility testing and cultivation of highly fastidious bacterial strains.

 

DTU Biosustain

DTU Biosustain

Jen Kindtler

VP Research and Development

 

 

ETH Zurich

ETH Zurich

Christophe Lacroix

Professor

Public university

 

everImmune

everImmune

Karine Roget

CSO (interim)

everImmune leverages the potential of the gut microbiota for the development of therapeutic (Oncobax®) and diagnosis tools in cancer.

 

Ferring Pharmaceuticals

Ferring Pharmaceuticals

Michelle Carr

Senior Growth Project Manager

Ferring Pharmaceuticals is a research-driven, specialty biopharmaceutical group committed to helping people around the world build families and live better lives.

 

Freya Biosciences

Freya Biosciences

Johan E.T. van Hylckama Vlieg

CSO & Co-founder

Freya™ is a clinical-stage company taking an innovative approach to women’s health, with microbial immunotherapies aimed at relieving the chronic inflammation underlying a range of reproductive system diseases uniquely afflicting women.

  

GenoScreen

GenoScreen

Pierre Burguière

Deputy CEO

GenoScren is a French biotech with 20+ years of expertise – we develop cutting-edge end-to-end analytical solutions to decipher microbiome (gut, skin, soil) compositions and functions.

 

GMT Science

GMT Science

Etienne Formstecher

CEO

GMT Science develops routine, CE-marked microbiome analysis to improve the clinical management of chronic diseases.

 

Hallym University

Hallym University

Suenie Park

Professor

Hallym University is a four-year private university set at the foot of Bong Ui Mountain in central Chuncheon. Since its foundation in 1982, the university has strived to nurture its students into leaders of tomorrow. Located one-hour east of Seoul and served by world class transportation links, Chuncheon serves as the gateway as well as the capital of the province of Gangwon-do.

 

Hospital-ASST Bergamo Est

Hospital-ASST Bergamo Est

Fabio Pace (MD)

GI Unit Director

ASST Bergamo Est Hospital

Lombardy region, Italy

 

ICO

ICO

Sidonie LAVERGNE

Scientific Director & Director of Translational Research

Integrated Cancer Center

 

ICOSA

ICOSA

Caroline de Mareuil-Villette

European Patent Attorney

ICOSA is a Patent Law Firm specialized in Healthcare, and deeply involved in protecting microbiome-related inventions.

 

IFF

IFF

Charlotte Storni

Global Regulatory Strategy Lead Biopharma

Inspired by nature and distinguished by our world-class bioscience and microbiome capabilities, IFF’s Health & Biosciences (H&B) division is a leading innovation partner for customers across a broad range of markets and industries.

 

INRAE

INRAE

Patrick Veiga

Gut Microbiome & Nutrition Research Research Director

INRAE is committed to exploring the frontiers of science and performing high-calibre research that is globally relevant. The institute makes major contributions to European research and participates in European research programmes (e.g., via research networks, H2020 research projects, Marie Skłodowska-Curie Actions) and, as a result, is currently developing bilateral and trilateral partnerships. Our international collaborations focus on sharing laboratories or infrastructure, becoming integrated into research networks, and playing a role within international organisations.

 

INRAE Transfert Genome and Transcriptome

INRAE Transfert Genome and Transcriptome

Marina Moletta-Denat

Business development

GeT-IT offers a range of services based on innovations from INRAE that meet the expectations and needs of companies in genomic and transcriptomic applications or R and D projects.

 

Institut Pasteur Lille France

Institut Pasteur Lille France

Catherine DANIEL

Principal Investigator, Senior Researcher

Cancers, infectious diseases (COVID-19, tuberculosis, whooping cough, etc.), cardiovascular diseases, Alzheimer's disease, inflammatory diseases, diabetes, ...34 research teams are working every day to understand and fight against these diseases, to slow their development, to imagine tomorrow's treatments and to change behavior.

 

Lactosan GmbH

Lactosan GmbH

Peter Ladinig

Head of production

Lactosan Pharma offers contract manufacturing for APIs basing on microorganisms according to GMP/cGMP standards. The production plant features a 1,000 l fermentation tank and a freeze-drying unit.

Lallemand Health Solutions

Lallemand Health Solutions

Sylvie Binda

Vice President Research & Development

Pioneer in the probiotic industry since 1934, LHS provides probiotic products with solid scientific research, custom formulations and unique customer service to its partners in more than 60 countries.

 

Mbiomics Gmbh

Mbiomics Gmbh

Markus Rinecker

Managing Director and Co-Founder

mbiomics offers a unique combination of fast, quantitave and accurate analysis of the microbiome.

 

Metabolon

Metabolon

Raffy Demirdjian

Sales and Business Development Director, France & Belgium

Metabolon, Inc. is the global leader in metabolomics, with a mission to deliver biochemical data and insights that expand and accelerate the impact of life sciences research.

 

Microba Life Sciences

Microba Life Sciences

Kylie Ellis

Head of Research Services

Microba Life Sciences is a precision microbiome company powering discovery to improve human health by employing a human-first data-driven approach to identifying therapeutic leads.

 

Microbiotica

Microbiotica

Adam Wilkinson

VP Pre-Clinical Development

Microbiome biomarker and drug development company with a world-leading microbiome analysis platform.

 

MRM Health NV

MRM Health NV

Selin Bolca

Director Pharmaceutical Development and Manufacturing

Unlocking the full potential of the gut microbiome for development of effective therapeutics through our proprietary CORAL™ consortia optimization and single-process manufacturing technology.

 

NBX Biosciences

NBX Biosciences

Damien Rei

CEO

Startup developing gut microbiota derived treatment against neurodegenerative diseases

 

Neobe Therapeutics

Neobe Therapeutics

Pedro Correa de Sampaio

CEO

Neobe is building a platform for the engineering of live biotherapeutics aimed at removing stromal barriers to immune infiltration in solid tumours, in order to enable existing immunotherapies in current non responding cancer patients.

 

Nestlé Health Science

Nestlé Health Science

Laurent Ameye

Global Regulatory Compliance Manager

Our expertise areas includes food supplements, medical nutrition, and pharmaceutical solutions on areas including food allergies, metabolic/gastrointestinal health, healthy aging and adult acute care.

 

Nexbiome Therapeutics

Nexbiome Therapeutics

Stanislas Desjonquères

CEO

We transform academic therapeutic and microbiome-based projects into products for Humans. Our value is to source, fund and operate these projects.

 

NIZO

NIZO

Ioana Iorga

Business Development Manager

We support the discovery, development, up-scaling and (pilot) production of microbiome-based products, including dietary supplements (pro-/post- and synbiotics) and LBPs.

 

Orion Corporation Orion Pharma R&D

Orion Corporation Orion Pharma R&D

Mirja Huhtinen

Director, Animal Health R&D

Orion Pharma Animal Health R&D develops innovative medicinal, ProHealth and microbiome products to global markets. Our flagship microbiome product is Broilact.

 

PharmaBiome AG

PharmaBiome AG

Tomas de Wouters

Co-Founder & CEO

Pioneering the development of microbiome-based therapies using proprietary tools for their design and production.

 

Phycell (INSERM U1003) – University of Lille

Phycell (INSERM U1003) – University of Lille

Mathias Chamalliard

Research Director at INSERM - Deputy Director of the Laboratory of Cell Physiology

The Chamaillard laboratory is interested in defining how mucosal immune response to the microbiota contribute to microbial tolerance, host defense and antitumoral immunity, and how deregulation of these processes break down in Crohn's disease and colitis-associated colorectal cancer. Crohn's disease affects millions of individuals worldwide through the influence of several genetic and environmental factors.

 

PiLeje

PiLeje

Pascaline Gervoson

CEO

PiLeJe’s purpose is to promote the health of each individual and maintain it for as long as possible. This is achieved by applying what Dr Christian Leclerc, the Group’s founder, calls “health-based medicine”.

 

POSTECH

POSTECH

Sin-hyeog Im

Professor

Pohang University of Science and Technology is devoted to nurturing the leaders who make a difference globally, conducting cutting-edge research with outcomes that transform our daily lives, and directly contributing to the betterment of society through science and technology.

 

Probiotical Research

Probiotical Research

Marco Pane

CSO

Probiotical is an Italian family-owned company specialized since 1985 in probiotics manufacture, from the raw material to the finished products, with very high quality, guaranteed stability and scientifically backed strains. We are driving innovation in a variety of functionalities and technologies.

 

ProDigest BV

ProDigest BV

Massimo Marzorati

CEO

The most complete in vitro technology platform (from high-throughput to detailed MoA) to assess the fate of Microbiome-based medicinal products along the GI tract.

 

PROGE FARM S.r.l.

PROGE FARM S.r.l.

Antonella Bonetti

Regulatory Affairs Manager

PROGE FARM develops, produces, registers (even as medicine) and put on the markets, directly or through licensees, its products based on selected patented probiotic strains.

 

Quadram Institute

Quadram Institute

Graeme Brown

CBO

At the forefront of research into food, the gut microbiome, and human health, the Quadram is a unique partnership between Quadram Institute Bioscience, the Norfolk and Norwich University Hospitals NHS Foundation Trust and the University of East Anglia (UEA).

 

Recolony

Recolony

Ana Montalban-Arques

CEO Recolony

Recolony focuses on the development of a live biotherapeutic product for the treatment or prevention of colorectal cancer.

 

Sanofi Consumer Healthcare

Sanofi Consumer Healthcare

 

 

Seventure Partners

Seventure Partners

Isabelle de Cremoux

CEO & Managing Partner

Seventure Partners finances the development of innovative companies within Life sciences and Digital technologies. We have 20 years of experience which has enabled Seventure to acquire expertise and networks in these two fields which services the needs of entrepreneurs.

 

SGS Quay Pharma

SGS Quay Pharma

Michael Kruidenier

Head of BD

No other CDMO has the breadth of knowledge in the formulation services we offer, our clinical trials manufacturing and supply know how as well as our specialist knowledge in providing cost efficient engineering solutions to meet the many challenges that we know can accompany the finished product manufacture of microbial therapies.

 

Siolta Therapeutics

Siolta Therapeutics

Nikole Kimes

CEO & Founder

Siolta Therapeutics is a clinical-stage biotech company on a mission to alleviate the suffering of millions impacted by chronic inflammatory diseases through novel microbiome-based medicines.

 

Spanish National Research Council (IATA-CSIC)

Spanish National Research Council (IATA-CSIC)

Yolanda Sanz

Full Professor

Microbiome, Intestinal Human Bacteria, Immunity, Body-Brain Interactions, Diet, Obesity, Diabetes, Cardiovascular Disease, Mood, Comorbidities, Microbiome-Based Diagnosis, Prevention and Therapy, Microbiome-Directed Nutrition.

 

Starfish Bioscience

Starfish Bioscience

Sandrine Claus

Founder & CEO

Regenerating soil microbiomes

 

Taiwan Microbiota Consortium

Taiwan Microbiota Consortium

Chun-Ying Wu

Chair

The Taiwan Microbiota Consortium consists of a group of government-related management unit personnel, medical professionals, biotech and pharmaceutical industry representatives, and academic research experts, etc., who jointly form a cross-field, cross-institutional industry-government-university-research cooperation and exchange network. The main purpose of our establishment is to promote academic research and application related to microorganisms  
Univ Beira Intérior

Univ Beira Intérior

Ana Palmeira-de-Oliveira

Invited Professor

The University of Beira Interior (UBI), is a Portuguese institution of higher education in expansion, reaching the status of academy, which welcomes students from all regions of the country and international students from dozens of nationalities, namely from Portuguese-speaking countries and Latin America.

 

UMRF 0545 / Université Clermont Auvergne

UMRF 0545 / Université Clermont Auvergne

Stéphanie Bornes

Professor

 

 

Université Grenoble alpes

Université Grenoble alpes

Audrey Le Goellec

MCU-PH

A multidisciplinary institution located in the heart of the French Alps, Université Grenoble Alpes (UGA) is renowned for its scientific and technological research activities, aimed at providing essential training to students and faculty and at addressing societal issues.

 

University College Cork

University College Cork

Siobhain O'Mahony

Lecturer and Principal Investigator

World-class Undergraduate and Postgraduate Education in Ireland

 

University of Ghent

University of Ghent

Tom Van de Wiele

Full Professor

Ghent University is a top 100 university and one of the major universities in Belgium. Our 11 faculties offer more than 200 courses and conduct in-depth research within a wide range of scientific domains. Ghent University Global Campus is also the first European university in Songdo, South Korea.

 

University of Queensland Australia

University of Queensland Australia

Anders Cervin

Professor

The University of Queensland (UQ) is one of Australia’s leading research and teaching institutions. We strive for excellence through the creation, preservation, transfer and application of knowledge. For more than a century, we have educated and worked with outstanding people to deliver knowledge leadership for a better world.

 

Vaiomer

Vaiomer

Anne Deflisque

Sales & Marketing Director

Pioneer explorers of low bacterial biomass samples, we pave the way to blood and tissue microbiome research.

 

VetAgro Sup

VetAgro Sup

Laurent Rios

Professor

VetAgro Sup is an institution of higher education and research (ESR) under the aegis of the French Ministry of Agriculture and Food. It is the only establishment in France that trains veterinarians, agricultural engineers, and veterinary public health inspectors.

 

Voisin Consulting Life Sciences (VCLS)

Voisin Consulting Life Sciences (VCLS)

Clara Desvignes

Director, Drugs, Medical Devices & Microbiome-based products

VCLS collaborates with developers to strategically position their microbiome-based products, creating a roadmap to hit product development milestone, and achieve the commercial success.

 

Yakult Europe BV

Yakult Europe BV

Bruno Pot

Science Director Europe

Global probiotic product producer.

Zymo Research Europe GmbH

Zymo Research Europe GmbH

Dr. Thomas Kuri

Managing Director

Zymo Research is a globally established biotechnology company and industry leader in the fields of epigenetics, microbiomics and the emerging Next-Gen Sequencing space.